Outcomes of linezolid, glycopeptides, and other regimens in ampicillin-resistant, vancomycin-susceptible and vancomycin-resistant enterococcal bacteremia in a resource-limited setting: stewardship implications

Naunyn Schmiedebergs Arch Pharmacol. 2026 Jul 12. doi: 10.1007/s00210-026-05701-2. Online ahead of print.ABSTRACTEnterococcal bloodstream infections (BSI) are associated with high morbidity and limited treatment options, particularly in resource-limited settings where access to standard agents may b

Y Yameena Noman Khan